EUVIMEDEUVIMED entdecken
Klinische Studie

Magnetic Resonance Imaging-guided Transurethral Ultrasound Ablation (TULSA) of Localized Prostate Cancer: A prospective Trial

Thibault Tricard, Roberto Luigi Cazzato, Alice Schroeder, Michel De Mathelin, Clara Barhoumi, Victor Gaillard, Erik Sauleau, Afshin Gangi, Hervé Lang

Journal of Vascular and Interventional Radiology · 2025-09 · 36 (9) · 1401-1408

DOI: 10.1016/j.jvir.2025.05.024 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Journal of Vascular and Interventional Radiology, 2025-09. Verfasst von Thibault Tricard und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Nouvel Hôpital Civil, CHRU Strasbourg, Strasbourg, France; ICube UMR 7357, Illkirch, France. Electronic address: thibault.tric…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Magnetic Resonance Imaging, Interventional, High-Intensity Focused Ultrasound Ablation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To evaluate the effectiveness and safety of the TULSA-PRO device in treating organ-confined low-risk to intermediate-risk prostate cancer (PCa). MATERIALS AND METHODS: This prospective, single-center clinical trial included 25 men with organ-confined low-risk/intermediate-risk PCa (prostate-specific antigen ≤ 15 ng/mL, International Society of Urological Pathology ≤ 2, magnetic resonance [MR] imaging ≤ iT2c). Patients underwent MR imaging-guided focused ultrasound treatment, followed by clinical reevaluation at 1, 3, 6, and 12 months. The primary end point was the absence of clinically significant cancer (CSC) on the 12-month systematic and targeted biopsy. Secondary end points included safety, quality of life, prostate-specific antigen variation, and functional outcomes. RESULTS: At 12 months, 43.5% of patients (10/23) had CSC on biopsy, with a recurrence-free survival rate of 40% and a treatment-free survival rate of 72% after a median follow-up of 37 months (range, 14-54 months). Functional outcomes revealed stress urinary incontinence in 6 patients, overactive bladder in 8, and severe erectile dysfunction in 7 of the 13 preprocedurally potent patients. Otherwise, the safety profile was favorable, with no severe adverse event related to the treatment. MR imaging follow-up detected suspicious lesions in 3 of the 10 (30%) patients with CSC at 12 months. CONCLUSIONS: Transurethral ultrasound ablation shows promise as a focal treatment for localized PCa, although it may not be universally curative. Continued surveillance and further studies are required to assess long-term effectiveness and to optimize functional outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsMagnetic Resonance Imaging, InterventionalHigh-Intensity Focused Ultrasound AblationHumansMaleProspective StudiesAgedMiddle AgedTreatment OutcomeTime FactorsProstate-Specific AntigenQuality of LifeKallikreinsProgression-Free SurvivalRisk FactorsAged, 80 and overPredictive Value of Tests

Substanzen

Prostate-Specific AntigenKallikreinsKLK3 protein, human

Autor:innen und Institutionen

  • Department of Urology, Nouvel Hôpital Civil, CHRU Strasbourg, Strasbourg, France; ICube UMR 7357, Illkirch, France. Electronic address: thibault.tricard@chru-strasbourg.fr.
  • ICube UMR 7357 - Laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie 300 bd Sébastien Brant -67412 Illkirch.
  • Department of Urology, Nouvel Hôpital Civil, CHRU Strasbourg, Strasbourg, France.
  • ICube UMR 7357, Illkirch, France.
  • Pôle Santé Publique, Hôpitaux Universitaires de Strasbourg, France.

Zitieren

APA

Tricard, T., Cazzato, R. L., Schroeder, A., De Mathelin, M., Barhoumi, C., Gaillard, V., Sauleau, E., Gangi, A., & Lang, H. (2025). Magnetic Resonance Imaging-guided Transurethral Ultrasound Ablation (TULSA) of Localized Prostate Cancer: A prospective Trial. Journal of Vascular and Interventional Radiology, 36(9), 1401-1408. https://doi.org/10.1016/j.jvir.2025.05.024

Vancouver

Tricard T, Cazzato RL, Schroeder A, De Mathelin M, Barhoumi C, Gaillard V, et al. Magnetic Resonance Imaging-guided Transurethral Ultrasound Ablation (TULSA) of Localized Prostate Cancer: A prospective Trial. Journal of Vascular and Interventional Radiology. 2025;36(9):1401-1408. doi:10.1016/j.jvir.2025.05.024

BibTeX
@article{Tricard2025,
  author = {Tricard, Thibault and Cazzato, Roberto Luigi and Schroeder, Alice and De Mathelin, Michel and Barhoumi, Clara and Gaillard, Victor and Sauleau, Erik and Gangi, Afshin and Lang, Hervé},
  title = {Magnetic Resonance Imaging-guided Transurethral Ultrasound Ablation (TULSA) of Localized Prostate Cancer: A prospective Trial},
  journal = {Journal of Vascular and Interventional Radiology},
  year = {2025},
  volume = {36},
  number = {9},
  pages = {1401--1408},
  doi = {10.1016/j.jvir.2025.05.024}
}
Kostenlos starten →